Essentials Of Translational Pediatric Drug Development PDF
It is an amazing Business & Economics book written by Elke Gasthuys and published by Academic Press. This book was released on 17 January 2023 with total pages 670. Read book in PDF, EPUB and Kindle directly from your devices anywhere anytime. Click Download button to get Essentials of Translational Pediatric Drug Development book now. This site is like a library, Use search box to get ebook that you want.

- Author : Elke Gasthuys
- Release Date : 17 January 2023
- Publisher : Academic Press
- Genre : Business & Economics
- Pages : 670
- ISBN 13 : 0323884598
- Total Download : 375
- File Size : 53,8 Mb
Essentials of Translational Pediatric Drug Development PDF Summary
Despite the broad consensus that children merit the same quality of drug treatment as any other age group, children remain frequently neglected during drug research and development. Even with the adoption of multiple legislations addressing this problem, the lack of efficacy and safety data of marketed as well as newly developed drugs still remain in the pediatric population. Essentials of Translational Pediatric Drug Development: From Past needs to Future Opportunities provides integrated up-to-date insights relevant for both translational researchers and clinicians active in the field of pediatric drug development. The book covers all key aspects of pediatric drug development from different stakeholder perspectives and will provide a literature overview and careful reflection of the state-of-the-art approaches that are used. The book will be a guide for researchers in the field to design and to perform high quality, innovative pediatric-adapted drug development by defining needs/challenges as well as possible solutions to advance and to harmonize pediatric drug development. Covers both theoretical and practical aspects of translational pediatric drug development Approaches the topic from different stakeholder perspectives (academics, industry, regulators, clinicians, patient/parent advocacy groups) Offers best practices and future perspectives for improvement of translational pediatric drug development